# Risk of GAstric Adenocarcinoma After Cephalic Duodenopancreatectomy

> **NCT03991065** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 800 (estimated)

## Conditions studied

- Cephalic Duodenopancreatectomy 10 or More Years Ago

## Interventions

- **DIAGNOSTIC_TEST:** high digestive endoscopy

## Key facts

- **NCT ID:** NCT03991065
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-16
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-03-31
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2023-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03991065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03991065, "Risk of GAstric Adenocarcinoma After Cephalic Duodenopancreatectomy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03991065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*